FDLI makes leadership appointment
This article was originally published in Scrip
Executive Summary
The Food and Drug Law Institute (FDLI) has named former US FDA chief of staff Susan Winckler as the group's new president and CEO. She replaces James Kelley, who announced his departure in the summer. Ms Winckler is a pharmacist and attorney who served as FDA chief of staff from January 2007 to June 2009. She was most recently managing director of the medical products practice at Leavitt Partners, a consulting firm headed by former Health and Human Services secretary Mike Leavitt.